Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Claviez A et al. - Children and adolescents with relapsed and refractory HL show reasonable results with allogeneic HSCT. Especially those patients allografted in recent years with good performance status and chemosensitive disease show highly encouraging results. Because relapse remains the major cause for treatment failure, additional efforts to improve disease control are necessary.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address